Not applicableStudy completedNCT01211288What this trial is testingLongitudinal Study of Dental Implant Therapy in HIV Positive PatientsWho this might be right forDental Implant University of Alabama at Birmingham 41
Post-approval studies (Phase 4)Study completedNCT01608269What this trial is testingNucleoside Switch Pilot for Virologically Controlled HIV Subjects With Decreasing CD4 Cells Who Have Received TDF-based ARV TherapyWho this might be right forHiV1- Positive Therapeutic Concepts 30
Not applicableStudy completedNCT01705041What this trial is testingPreliminary Evaluation of a Point-Of-Care Liver Function TestWho this might be right forHIVTuberculosisDrug-Induced Liver Injury PATH 700
Not applicableStudy completedNCT05868005What this trial is testingDelivering a Multi-disease Screening Tool to Migrant PopulationsWho this might be right forHivHepatitis BHepatitis C+7 more Barcelona Institute for Global Health 980
Not applicableStudy completedNCT01611402What this trial is testingGene Expression in HIV and Tuberculosis Co-infectionWho this might be right forTuberculosis National Institute of Allergy and Infectious Diseases (NIAID) 96
Not applicableStudy completedNCT00106795What this trial is testingRelationship Between Fatigue and Mitochondrial Damage in Patients With HIV/AIDSWho this might be right forHIV InfectionsFatigueHIV Positive+3 more National Institute of Allergy and Infectious Diseases (NIAID) 82
Not applicableStudy completedNCT00000895What this trial is testingLearn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV InfectionWho this might be right forMycobacterium Avium-intracellulare InfectionHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 85
Post-approval studies (Phase 4)UnknownNCT04270773What this trial is testingImmunogenicity and Safety of a 9-valent Human Papillomavirus Vaccine in HIV-positive WomenWho this might be right forHIV InfectionsHPV Infection University Hospital Virgen de las Nieves 158
Early research (Phase 1)Study completedNCT02012556What this trial is testingPharmacokinetic and Pharmacodynamic Study of TH9507, a Growth Hormone-Releasing Factor Analog, in HIV Positive PatientsWho this might be right forHIV Theratechnologies 18
Not applicableLooking for participantsNCT07117370What this trial is testingAssessing the Feasibility of Coach Mpilo for Men With TB and HIVWho this might be right forTuberculosisHIV Arizona State University 240
Large-scale testing (Phase 3)Study completedNCT02537236What this trial is testingOmega-3 Supplementation in HIV Patients With Therapeutic Lifestyle Change Diet.Who this might be right forHuman Immunodeficiency Virus Instituto Mexicano del Seguro Social 200
Not applicableStudy completedNCT02926456What this trial is testingStudy in HIV1-Positive, Virosuppressed Patients Currently inTreatment With Ritonavir-Boosted Protease Inhibitors (PI/r) Starting Cobicistat-Boosted Darunavir (DRV/c - Rezolsta)Who this might be right forHuman Immunodeficiency Virus Janssen-Cilag S.p.A. 337
Post-approval studies (Phase 4)Ended earlyNCT01014481What this trial is testingAppropriate Timing of HAART in Co-infected HIV/TB PatientsWho this might be right forHIV InfectionsTuberculosis Bamrasnaradura Infectious Diseases Institute 156
Not applicableStudy completedNCT00023387What this trial is testingTBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl RifapentineWho this might be right forTuberculosis Centers for Disease Control and Prevention 36
Post-approval studies (Phase 4)Study completedNCT01684787What this trial is testingStudy to Evaluate the Treatment for Chronic Hepatitis C With Normal Transaminases in HIV Positive PatientsWho this might be right forChronic Hepatitis C Miguel Santin 80
Not applicableActive Not RecruitingNCT02129244What this trial is testingA Nurse Case Management Intervention to Improve MDR-TB/HIV Co-Infection OutcomesWho this might be right forMDR-TBHIV Johns Hopkins University 3,600
Large-scale testing (Phase 3)Study completedNCT01968551What this trial is testingPhase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive AdultsWho this might be right forHIV-1HIV InfectionsAcquired Immunodeficiency Syndrome Gilead Sciences 158
Not applicableStudy completedNCT00218712What this trial is testingSpecialized Cognitive-Behavioral Counseling Intervention to Reduce HIV Transmission Risk Behavior in HIV-Infected MenWho this might be right forHIV Infections University of California, San Francisco 488
Not applicableStudy completedNCT03367130What this trial is testingImproving Clinic Attendance for Medication Collection Among HIV Positive Individuals in NepalWho this might be right forHIV InfectionsAntiretroviral TherapyHIV Seropositivity Tokyo University 468
Not applicableStudy completedNCT01770730What this trial is testingA Trial of the Urine LAM Strip Test for TB Diagnosis Amongst Hospitalized HIV-infected PatientsWho this might be right forTuberculosis University of Cape Town 2,618